Evidence map›Paper›PMID 37266542›Full record

ArticleFrontiers in neuroscience2023

Editorial: Recent advances in mechanisms and therapeutics for Fragile X Syndrome and autism.

Gemma Molinaro, Kimberly M Huber, Elizabeth A McCullagh, Sophie R Thomson

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gemma MolinaroDepartment of Neuroscience, O'Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Kimberly M HuberDepartment of Neuroscience, O'Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Elizabeth A McCullaghDepartment of Integrative Biology, Oklahoma State University, Stillwater, OK, United States.
Sophie R ThomsonCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.

Funding

Neurophysiological and acute pharmacological studies in FXS patientsU54HD082008 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI HUBER, KIMBERLY M. · 2014 to 2019
$9.8M
Sex-specific mechanisms of cortical circuit dysfunction in a mouse ASD modelR37NS114516 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI KIMBERLY M. HUBER · 2020 to 2026
$3.7M
Myelination Deficits Underlying Auditory Issues in Fragile X SyndromeR15HD105231 · NICHD · OKLAHOMA STATE UNIVERSITY STILLWATER · PI MCCULLAGH, ELIZABETH ANNE · 2021 to 2025
$1.4M
NICHD NIH HHS R15 HD105231NICHD NIH HHS U54 HD082008NINDS NIH HHS R37 NS114516
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autism spectrum disorders (ASDs)E/I imbalanceFragile X Syndrome (FXS)microbiometherapeutics

Identifiers

PMID37266542
PMCPMC10230571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.